Human embryonic kidney
293T cells (HEK293T cells) before and after
treatment with silver nanoparticles (AgNPs) were measured using advanced
atomic force microscopy (AFM) force measurement technique, and the
biomechanical property of cells was analyzed using a theoretical model.
The biomechanical results showed that the factor of viscosity of untreated
HEK293T cells reduced from 0.65 to 0.40 for cells exposure to 40 μg/mL
of AgNPs. Comet assay indicated that significant DNA damage occurred
in the treated cells, measured as tail DNA% and tail moment. Furthermore,
gene expression analysis showed that for the cells treated with 40
μg/mL of AgNPs, the antiapoptosis genes Bcl2-t and Bclw were, respectively, downregulated to 0.65-
and 0.66-fold of control, and that the proapoptosis gene Bid was upregulated to 1.55-fold of control, which indicates that apoptosis
occurred in cells exposed to AgNPs. Interestingly, excellent negative
correlations were found between the factor of viscosity and tail DNA%,
and tail moment, which suggest that the biomechanical property can
be correlated with genotoxicity of nanoparticles on the cells. Based
on the above results, we conclude that (1) AgNPs can lead to biomechanical
changes in HEK293T cells, concomitantly with biological changes including
cell viability, DNA damage, and cell apoptosis; (2) the factor of
viscosity can be exploited as a promising label-free biomechanical
marker to assess the nanotoxicity of nanoparticles on the cells; and
(3) the combination of AFM-based mechanical technique with conventional
biological methods can provide more comprehensive understanding of
the nanotoxicity of nanoparticles than merely by using the biological
techniques.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.